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Multiple sclerosis (MS) is a chronic inflammatory disease mediated by a complex
interaction between the autoreactive lymphocytes and the effector myeloid cells within
the central nervous system (CNS). In a murine model of MS, experimental autoimmune
encephalomyelitis (EAE), Ly6Chi monocytes migrate into the CNS and further differentiate
into antigen-presenting cells (APCs) during disease progression. Currently, there is no
information about gene signatures that can distinguish between monocytes and the
monocyte-derived APCs. We developed a surface marker-based strategy to distinguish
between these two cell types during the stage of EAE when the clinical symptoms
were most severe, and performed transcriptome analysis to compare their gene
expression. We report here that the inflammatory CNS environment substantially alters
gene expression of monocytes, compared to the monocyte differentiation process within
CNS. Monocytes in the CNS express genes that encode proinflammatory cytokines
and chemokines, and their expression is mostly maintained when the cells differentiate.
Moreover, monocyte-derived APCs express surface markers associated with both
dendritic cells and macrophages, and have a significant up-regulation of genes that are
critical for antigen presentation. Furthermore, we found that Ccl17, Ccl22, and Ccr7 are
expressed in monocyte-derived APCs but not the Ly6Chi monocytes. These findings
may shed light on identifying molecular signals that control monocyte differentiation and
functions during EAE.
Keywords: multiple sclerosis, experimental autoimmune encephalomyelitis, monocytes, antigen-presenting cells,
RNA-Seq
INTRODUCTION
Multiple sclerosis (MS) is one of the most common neurological disorders among young adults.
The etiology of MS is not known but it is widely accepted that it is autoimmune in nature.
Current disease modifying agents (DMAs) for MS treatments reduce the rate of relapses, but these
treatments do not effectively prevent disease progression (1, 2). This suggests that more effective
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therapeutic strategies are needed to prevent the progression of
MS. Brain autopsy studies revealed that mononuclear myeloid
cells are abundantly found in the active demyelinating lesions
of patients with MS (3). It has also been demonstrated
that mononuclear myeloid cells can directly mediate
inflammation, demyelination, and axonal damage (4, 5).
Consequently, these cells are an ideal target for novel
MS therapies.
The role of mononuclear myeloid cells in neuroinflammation
has been elucidated using experimental autoimmune
encephalomyelitis, a murine model for MS research (4, 5). Under
homeostatic conditions, parenchymal-resident microglia and
the non-parenchymal CNS-associated macrophages, including
perivascular, meningeal, and choroid plexus macrophages, are
responsible for sensing pathogen invasion within the CNS.
The phagocytic capability of these cells allows the clearance
of pathogens, and cell debris following tissue damage. During
the onset of aberrant inflammation in EAE, monocytes
migrate to the CNS from the periphery and become the
dominant myeloid cell type that promotes inflammation (6, 7).
Monocytes are of hematopoietic origin and can be broadly
divided into the classical Ly6Chi CCR2+ CX3CR1
low and
the non-classical Ly6Clow CCR2− CX3CR1
hi types (8, 9).
Classical monocytes are known to play a critical role in the
pathogenesis of EAE, given that the CCR2-deficient mice do
not develop the disease (10, 11). Upon arrival to the CNS,
classical monocytes differentiate into antigen-presenting cells
(APCs), via an unidentified signal (12). Unlike monocytes
cultured in vitro with granulocyte-macrophage colony-
stimulating factor (GM-CSF) and M-CSF, which differentiate
into dendritic cells (moDCs) and macrophages (moMs),
respectively, monocyte differentiation under inflammatory
conditions in vivo is likely controlled by multiple signals
(12–14). Although morphologically undistinguishable from
microglia, recent studies suggest that the monocyte-derived
APCs promote neuroinflammation during the course of
EAE, whereas microglia protect the CNS by clearing debris
(15). Therefore, identifying key molecules and pathways
that potentially trigger monocyte differentiation into APCs,
or distinguish these two cell types may help develop novel
therapeutic strategies.
Using fluorescence activated cell sorting coupled with
RNA-Seq analysis, we compared the transcriptomes of
monocytes isolated from the bone marrow, and monocytes
and monocyte-derived APCs from the spinal cords of mice
during the peak stage of EAE when the clinical symptoms
were most severe. Our primary focus was on the expression
of cytokines, chemokines and their respective receptors,
immunoregulatory molecules, and transcription factors. Here
we report a substantial difference in gene expression profiles in
the bone marrow monocytes compared to the CNS-infiltrated
monocytes. In addition, CNS-infiltrated monocytes have a
gene signature that is distinct from the monocyte-derived
APCs. Furthermore, we propose that the expression of Ccl17,
Ccl22, and Ccr7 may serve as marker genes to distinguish




Ten to twelve-week-old female mice on a C57BL/6J background
were used. The mice were housed and bred under specific-
pathogen-free conditions in the vivarium at West Virginia
University Health Sciences Center. Mice were housed according
to the Institutional Animal Care and Use Committee (IACUC)
guidelines. Mice were maintained on a 12-h light/dark cycle
and were fed/watered ad libitum. All protocols and procedures
performed were approved by the IACUC of West Virginia
University, protocol number 1609003850.
Active Immunization for EAE Induction
Mice were lightly anesthetized with 2% isoflurane, then injected
subcutaneously at the upper and lower back with a total
of 200 µg of myelin oligodendrocyte glycoprotein (MOG)
peptide emulsified in complete Freund’s adjuvant (CFA) (Hooke
Laboratories, Lawrence, MA, USA). Pertussis toxin (250 ng) was
injected intraperitoneally at 2- and 24-h following the injection of
emulsion. Clinical scores measured physical disability. A 5-point
scale was used (Supplementary Figure 1).
Isolation of Monocytes and
Monocyte-Derived APCs From the Spinal
Cord and the Bone Marrow
Mice were sacrificed at the peak of EAE (14–15 days post-
induction). Spinal cords were isolated from the mice using the
previously described ejection method (16). Briefly, the skull was
removed from the mice exposing the brain. The lumbar column
was then exposed and cut transversely at the lower portion just
above the iliac crest. Ten milliliters of RPMI-10 medium was
rapidly injected from the lumen of the spinal canal using a 22G
needle. Spinal cords were digested with 1 mg/ml collagenase D
and 20 mg/ml DNase I (MilliporeSigma, St. Louis, MO, USA)
at 37◦C for 30min, then subjected to a discontinuous 30/70%
Percoll gradient centrifugation. Cells in the interphase were
collected, combined, and stained with the following antibodies:
CD45-PE/Cy7 (30-F11); CD11b-FITC (M1/70); CD64-APC
(X54-5/7.1); Ly6C-PE (HK1.4); and Ly6G-BV510 (1A8), all from
Biolegend, San Diego, CA, USA. Dead cells were excluded by
the LIVE/DEAD Fixable Near-IR stain (ThermoFisher Scientific,
Waltham, MA, USA). Monocytes, characterized as CD45+
CD11b+ CD64+ Ly6Chi Ly6G−, and monocyte-derived cells,
characterized as CD45+ CD11b+ CD64+ Ly6Clow/− Ly6G− were
sorted using the BD FACSAria III sorter.
To isolate monocytes from the bone marrow of the
mice, femurs and tibias were flushed with RPMI-10 medium.
Monocytes were first enriched using the monocyte isolation kit
(Miltenyi Biotec, Bergisch Gladbach, Germany), then stained
with CD45-PE/Cy7 (30-F11), CD11b-FITC (M1/70), Ly6C-PE
(HK1.4), Ly6G-BV510 (1A8), and CD11c-Percp/Cy5.5 (N418).
Bone marrow monocytes characterized as CD45+ CD11b+
Ly6Chi Ly6G− CD11c− were sorted using the BD FACSAria
III sorter.
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Assessing Monocyte Differentiation During
EAE
Mice were sacrificed at the priming phase (7 days post-induction)
or at the peak of EAE (14–15 days post-induction). Blood
(∼200 µl) was collected, and red blood cells were removed
by incubating with ACK lysis buffer. Cells from the spinal
cord and the bone marrow were obtained as described above.
Isolated cells were first incubated with anti-mouse CD16/CD32
(2.4G2, Fc block), then stained with the following antibodies
to identify monocytes and monocyte-derived APCs using BD
LSRFortessa: CD45-PE/Cy7 (30-F11), CD11b-FITC (M1/70),
CD64-APC (X54-5/7.1), Ly6C-PE (HK1.4), Ly6G-BV510 (1A8),
CCR2-BV421 (SA203G11), CD11c-Percp/Cy5.5 (N418), MHC
II-BV510 (M5/114.15.2), MerTK-APC (DS5MMER), and CD24-
BV421 (M1/69).
RNA Isolation, RNA-Seq Library
Preparation and Sequencing
RNA from the purified monocytes and monocyte-derived cells
was isolated using RNeasy Plus Mini Kit (Qiagen, Hilden,
Germany). Library preparation and sequencing were performed
at the Genomics Core Facility of West Virginia University
and Marshall University, respectively. RNA-Seq libraries were
built using KAPA mRNA HyperPrep Kit (KAPA Biosystems,
WilmingtonMA, USA) with 300 ng of total RNA and 11 cycles of
PCR according to manufacturer’s recommendation. The libraries
were quantified using Qubit Fluorometer, and the quality of the
libraries was determined by Bioanalyzer High Sensitivity DNA
Analysis (Agilent, Santa Clara, CA, USA). The libraries were
sequenced using the HiSeq 1500 system in high output mode to
generate 50 bp paired-end reads (Illumina, San Diego, CA, USA).
Bioinformatics Analysis
The SALMON package (17) was used to estimate expression
values using whole transcripts annotation from Gencode (vM22)
as a reference (18). Expression level of a protein-coding gene
was measured by TPM (transcripts per million) by pooling all
annotated transcript isoforms of the gene with an option “-g”
in SALMON. The TPM (log2) follows a bimodal distribution
and a threshold of two separated actively expressed genes from
those expressed at background level. A gene was defined as
differentially expressed by GFold (19) if a “Gfold” value (log2)
is higher than one, meaning that the probability of fold change
in expression being larger than two is 0.99 with default settings.
We further required DE gene to be actively expressed in at least
one of the compared conditions. Heat map visualization of gene
expression values were done by MeV (20).
Gene ontology enrichment analysis was done with the online
DAVID bioinformatics resource 6.8 (21). Genes that were actively
expressed in at least one of the analyzed cell types was included
as background. Redundant GO terms output from DAVID were
filtered by REVIGO (22) with default settings.
Statistical Analyses
Statistical comparison between samples was done by student’s
t-test. ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.001. NS, not
statistically different.
RESULTS
Identification of Monocytes and the
Monocyte-Derived APCs During EAE
During inflammation in the CNS, monocytes and monocyte-
derived APCs cannot be morphologically distinguished from
microglia, non-parenchymal CNS-associated macrophages, and
conventional dendritic cells (cDCs). To address this, we isolated
spinal cords from the EAE-induced mice at days 14–15 post-
immunization, in which the mice developed severe paralysis
(score = 3, Figure 1A). Using the ejection method for spinal
cord isolation we removed the leptomeninges and presumably
also the non-parenchyma CNS-associated macrophages (16).
Additionally, we isolated monocytes and monocyte-derived cells
using antibody-based cell sorting (Figure 1B). We first gated
on viable cells that highly expressed CD45, which represented
the hematopoietic-derived immune cells, but not microglia.
We then selected cells that expressed CD11b and CD64
(FcγRI). Selection of the CD64-positive cells excluded cDCs
as CD64 is expressed in monocytes and monocyte-derived
APCs, but not in cDCs (23). Since neutrophils also express
CD64, the CD64-positive cells were further selected with the
neutrophil marker, Ly6G. Finally, we distinguished monocytes
and monocyte-derived cells by the level of Ly6C expression,
since the expression of Ly6C is down-regulated during monocyte
differentiation (24). Cell that expressed an intermediate level of
Ly6C, which represented the partially differentiated monocytes,
were excluded. Without immunization, the percentage of
cells in the spinal cords that highly expressed CD45 was
<0.3% (Supplementary Figures 2A,B), and among those cells
the CD11b+ CD64+ monocytes and monocyte-derived cells
were nearly undetectable (Supplementary Figures 2A,C). This
observation indeed is reasonable because we do not expect
monocyte infiltration into the CNS without immunization. To
obtain a sufficient number of monocytes and monocyte-derived
cells for constructing RNA-Seq libraries, sorted cells from a total
of 18 mice from three independent experiments were combined.
To identify monocytes from the bone marrow during
EAE, viable CD45-positive cells were selected, followed
by exclusion of neutrophils and cDCs using antibodies
against Ly6G and CD11c. Monocytes were defined as
CD11bhi Ly6Chi population (Figure 1C). Sorted cells from
a total of 13 mice from two independent experiments
were combined.
Monocytes and Monocyte-Derived APCs
Express Signature Genes That Do Not
Overlap With the CNS-Associated
Macrophages and cDCs
Previous transcriptome analysis studies identified signature
genes that broadly characterize a mixed population of monocytes
and monocyte-derived cells, CNS-associated macrophages, non-
monocyte-derived cDCs, and microglia in healthy mice, during
EAE, or other neuroinflammatory conditions (25–33). A recent
study using single-cell RNA-Seq analysis demonstrated that cells
in the CNS expressing Ly6c2, Ccr2, Cd44, and Fcgr1 during
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FIGURE 1 | Identification of monocytes and the monocyte-derived APCs during EAE. (A) EAE was induced in female mice in C57BL/6J background by
active immunization. Disease severity, as determined by physical disability of themice, wasmeasured. Shown is a combine of three independent experiments with n= 11.
(Continued)
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FIGURE 1 | (B) At the peak of EAE (days 14–15), spinal cords were removed from the mice. Spinal cord monocytes (CD45+ CD11b+ CD64+ Ly6Chi Ly6G−, P1)
andmonocyte-derived APCs (CD45+ CD11b+ CD64+ Ly6Clow/− Ly6G−, P2) were purified by sorting. Shown are representative plots from three independent
experiments, with a total of 18 mice. (C) At the peak of EAE (days 14–15), bone marrow cells were isolated from the femurs and tibias from the mice. Bone marrow
monocytes (CD45+ CD11b+ Ly6Chi Ly6G− CD11c−, P3) were purified by sorting. Shown are representative plots from two independent experiments, with bone
marrow cells from 13 mice were combined.
EAE are likely from the monocytic origin (30). We found
that these four genes were highly expressed in monocytes
and the monocyte-derived APCs, together with two additional
signature genes that define the monocytes/monocyte-derived
cells, Plac8 and Nr4a1 (Figure 2). Specifically, the expression
of Cd44 distinguishes between monocyte-derived cells and
microglia (31). In addition, the expression level of signature
genes that identify CNS-associated macrophages (Mrc1, Lyve1,
Cd163, Siglec1, Pf4, Cbr2) and the non-monocyte-derived
cDCs (Flt3, Zbtb46, Batf3, Itgae, Clec9a), was either very
low or absent in our population identified as monocytes
or monocyte-derived APC. This suggests that our strategy
for isolating monocytes and monocyte-derived cells excluded
CNS-associated macrophages and cDCs (Figure 2). However,
we noted that although the expression level of macroglia-
associated markers Sall1, Slc2a5, Siglech, Bhlhe41, Gpr34, and
Serpine2 was low in monocytes and the monocyte-derived
APCs, the expression of Tmem119 and P2ry12 was slightly
increased in our monocyte-derived APC population (Figure 2).
Therefore, the presence of a small number of microglia
in this population of cells could not be excluded. Indeed,
when we compared the expression of Tmem119 in our
monocyte-derived APC population with the gene expression
profile of microglia that was previously reported (31), the
estimated microglia contamination in our monocyte-derived
APC population was up to 3.5% (Supplementary Figure 3).
Hexb and Trem2 were used previously to identify microglia
but they were also highly expressed in monocytes and
monocyte-derived APCs (Figure 2). Trem2 was shown to
be expressed in the inflammatory macrophages and has a
detrimental role in Alzheimer’s disease pathology (34). The
role of Hexb in monocytes is not clear, but we detected that
Hexb was highly expressed in the Ly6C+ monocytes isolated
from the bone marrow. These findings suggested that both
Trem2 and Hexb are not good markers to identify microglia
during EAE.
Monocyte-Derived APCs Express Gene
Signatures for Both Dendritic Cells and
Macrophages
Based on the expression of surface markers, monocytes can
differentiate into a heterogenous population of dendritic cells and
macrophages upon stimulation with GM-CSF in vitro (9, 35, 36).
We compared the signature genes for monocytes, dendritic cells,
and macrophages in three populations of cells that we have
isolated during EAE. Monocytes showed a high expression of
Ly6c and Ccr2 in the bone marrow. This expression was reduced
when these cells migrated to the spinal cord. Expression of Ly6c
and Ccr2 was further reduced when these cells differentiated
FIGURE 2 | Monocytes and monocyte-derived cells express signature genes
that are not overlapped by CNS-associated macrophages and cDCs.
Heatmap showing the expression of signature genes in monocyte/
monocyte-derived APCs, CNS-associated macrophages, cDCs, and
microglia. Signature genes for each cell type were identified based on previous
studies. Colors on the heatmap represent log2 values of TPM.
into APCs (Figures 3A,B). Correspondingly, we observed a
reduction in the surface marker expression of Ly6C and CCR2
in the CD45hi CD11b+ CD64+ Ly6G− cells isolated from the
spinal cord at the peak of EAE, suggesting that these cells were
differentiating monocytes (Figure 3C,E). Interestingly, during
the early phase of EAE when the mice did not yet develop any
disease symptoms, monocytes expressed high level of Ly6C and
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FIGURE 3 | The expression of Ly6C and CCR2 in monocytes is reduced during differentiation in the CNS. (A,B) The gene expression level of Ly6c1 (A) and Ccr2 (B)
in monocytes isolated from the bone marrow (BM-Mono) or spinal cords (SC-Mono), and the monocyte-derived APCs isolated from the spinal cords (SC-APC) at days
14–15 following EAE induction. Shown are TPM values from RNA-Seq analysis. (C–E) Spinal cord cells were isolated at days 14–15 (C) or day 7 (D) following EAE
induction. The expression of Ly6C and CCR2 in the CD45hi CD11bhi CD64+ Ly6G− cells was determined. Shown are representative plots from three independent
experiments, with a total of 10–11 animals in each time point. (E) Percentage of cells expressing Ly6C and CCR2 from individual animals is shown. ***P < 0.001.
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CCR2 compared to the stage when EAE symptoms were severe
(Figures 3D,E).
In contrast to the reduced expression of signature genes
for monocytes, expression of signature genes for dendritic
cells (Itgax, H2-Ab1, H2-Aa) and macrophages (Cd68, Mertk)
increased only during monocyte differentiation in the spinal
cord (Figures 4A–E). In addition, the expression of Cd74 was
increased in the spinal cord monocytes compared to the bone
marrow monocytes, and was further increased in the monocyte-
derived APCs (Figure 4F). CD74 plays a critical role in antigen
presentation because it mediates the assembly and trafficking of
the MHC II complexes (37). Consistent with the role of CD74,
recently studies demonstrated that the monocyte-derived cells
have prolonged T-cell interactions compared to the CNS-resident
macrophages andmacroglia during EAE (30). Our results suggest
that the differentiation of monocytes into APCs in the spinal cord
likely increases their antigen-presenting capability.
Since we detected an increased expression of genes that are
characteristic of dendritic cells and macrophages, we asked if the
monocyte-derived APCs we identified from the spinal cord were
FIGURE 4 | Monocyte-derived APCs expressed gene signatures for both dendritic cells and macrophages. (A–F) The gene expression level of Itgax (A), H2-Ab1 (B),
H2-Aa (C), Cd68 (D), Mertk (E), and Cd74 (F) in monocytes isolated from the bone marrow (BM-Mono) or spinal cords (SC-Mono), and the monocyte-derived APCs
isolated from the spinal cords (SC-APC) at days 14–15 following EAE induction. Shown are TPM values from RNA-Seq analysis. (G–J) Spinal cord cells were isolated
at days 14–15 (G) or day 7 (H) following EAE induction. The expression of surface markers for dendritic cells (CD11c, MHC II) and macrophages (MerTK, CD24) in the
CD45hi CD11bhi CD64+ Ly6G− cells or the CD45hi CD11bhi CD64− Ly6G− cells was determined. Shown are representative plots from three independent
experiments, with a total of 10–11 animals in each time point. (I) Percentage of cells expressing MerTK and CD24 within the CD11c/MHCII subpopulations from
individual animals is shown. (J) Percentage of cells expressing CD11c and MHCII within the CD64hi or CD64lo/− populations from individual animals is shown. *P <
0.05; **P < 0.01; ***P < 0.001. NS, not statistically different.
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a heterogenous population of dendritic cells and macrophages,
or if they were a single population of cells that contain a mixed
dendritic cell and macrophage phenotype. We isolated immune
cells from the spinal cords at the peak of EAE (day 14–15).
We used the expression CD11c and MHC II as markers for
dendritic cells, and the expression MerTK and CD24 as markers
for macrophages, as previously described (38). The expression
of MerTK has also been recently suggested to be a marker for
the ongoing differentiation of monocyte-derived macrophages
during EAE (30). We found that the majority of the CD45hi
CD64hi cells, representing cells from the monocyte origin,
expressed CD11c and/or MHCII (Figure 4G). Among these
cells, over 75% also expressed MerTK and CD24 (Figures 4G,I),
suggesting these are cells that display both dendritic cell and
macrophage phenotype. In contrast, only some of the CD45hi
CD64lo/− cells expressed CD11c and MHC II, and these cells did
not expressMerTK, suggesting that they were cDCs. Intriguingly,
when we analyzed the CD45hi CD64hi cells isolated from the
spinal cord at day 7 following EAE induction, in which the
mice did not start to have disease symptoms, the majority
of the cells (>75%) did not express CD11c, MHC II, and
MerTK (Figures 4H,J), suggesting that monocyte differentiation
correlates with disease severity.
The Inflammatory CNS Environment
Substantially Induces Monocyte Activation
We performed a global gene expression analysis of monocytes in
the bone marrow, along with monocytes and monocyte-derived
APCs, which migrated into the spinal cord during the peak of
EAE.We found that the gene expression profile of monocytes was
substantially changed from the bone marrow to the spinal cord,
with up-regulation of 1,140 and down-regulation of 1,322 genes
(fold-change> 2) (Figure 5A, Supplementary Tables 1, 2). Gene
ontology enrichment analysis on biological processes revealed
that the genes that were up-regulated were related to receptor
signaling, cellular response to cytokines, cell migration, and
cell activation (Figure 5B), whereas the genes that were down-
regulated in the spinal cord were mostly related to cell division
and proliferation (Figure 5C). Within the CNS, there were
relatively fewer changes in gene expression when monocytes
differentiated into APCs, with up-regulation of 152 and down-
regulation of 96 genes (Figure 5D, Supplementary Tables 3, 4).
Interestingly, the top categories of genes that were up-regulated
in the monocyte-derived APCs compared to the monocytes
were also related to cell activation, receptor signaling, and cell
migration (Figure 5E). In addition, genes related to antigen
processing and presentation, as well as cell differentiation were
also up-regulated in the APCs (Figure 5E). Genes that were
down-regulated during monocyte differentiation were related
to chemotaxis and defense response (Figure 5F). These data
suggest that cellular signals within an inflammatory CNS
environment induce a significant change in monocyte function,
followed by additional signals that initiate their differentiation.
In support to this notion, monocyte differentiation was not
observed in the bone marrow and the blood during the peak of
EAE (Figures 6A,B).
The Expression of Ccl17, Ccl22, and Ccr7
Distinguishes Monocytes From
Monocyte-Derived APCs
Monocyte migration into the CNS is critical for the pathogenesis
of EAE, which is demonstrated by studies showing that mice
lacking the major chemokine receptor for monocytes, CCR2, are
completely resistant to the disease (10, 11). We sought to predict
the pathological role of monocytes andmonocyte-derived cells in
the CNS by examining the expression of cytokines, chemokines,
and their receptors, as well as other key immunomodulatory
molecules in these cells. Compared to the monocytes in the bone
marrow, the expression of Il1a, Il1b, Il1rn, Osm, and Tnf were
the most significantly increased in the spinal cord monocytes
and the expression was maintained during their differentiation
(Figure 7A). The expression of Il6, Il18, and Il18bp was also
increased, albeit to a lesser extent (Figure 7A). This result is
consistent with the proinflammatory role of monocytes and the
monocyte-derived cells during EAE. The expression of several
cytokine receptors was also induced. Notably, the expression
of Csf1r and Csf2rb was induced in monocytes and monocyte-
derived APCs, and the expression Csf2ra was maintained at a
high level in the three populations of cells that we analyzed
(Figure 7B). Csf2ra and Csf2rb are subunits of the GM-CSF
receptor. Several studies have confirmed a critical role of GM-
CSF signaling in monocytes during EAE andMS. In addition, the
receptors of several common gamma chain (γc) cytokines were
induced in the spinal cord monocytes and monocyte-derived
APCs, including Il2rg, Il4r, Il7r, Il15r, and Il21r. This suggests
that IL-4, IL-7, IL-15, and IL-21 potentially play a role in these
cells. Interestingly, the expression of Ifngr1, Il17ra, Il6ra, and
Il6st was reduced in the spinal cord monocytes compared to the
monocytes in the bone marrow (Figure 7B).
A number of chemokine genes were up-regulated in the
monocytes following migration to the CNS, with the most
significant being Ccl2, Ccl3, Ccl4, Ccl5, Cxcl2, Cxcl9, Cxcl10,
Cxcl16 (Figure 7C). The expression levels of these genes were
maintained in the monocyte-derived APCs, with the exception
of Ccl2 and Cxcl10, which were down-regulated. Importantly, the
expression of Ccl17 and Ccl22 was absent in the bone marrow
monocytes and was only expressed at low levels in the spinal cord
monocytes, but the expression of these genes was significantly
induced in the monocyte-derived APCs (Figures 7E,F). A recent
study has shown that GM-CSF mediates CCL17 production in
human monocytes and murine macrophages (39). In addition,
mice lacking CCL17, CCL22, or their receptor, CCR4, develop
less severe EAE (40–42). Our data suggest that Ccl17 and Ccl22
can distinguish between monocytes and monocyte-derived cells
in the CNS during EAE. In addition, several chemokine receptor
genes were up-regulated in the spinal cord during the peak
of EAE, including Ccr1, Ccr5, Ccrl2, and Cxcr4 (Figure 7D).
Notably, similar to the expression of Ccl17 and Ccl22, Ccr7
was minimally expressed in the bone marrow and spinal cord
monocytes, but its expression was induced in monocyte-derived
APCs (Figure 7G). Although Ccr7 is also expressed in cDCs,
contamination with cDCs in our APC population is unlikely
as the expression of the cDC marker Zbtb46 was very low
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FIGURE 5 | The inflammatory CNS environment substantially induces monocyte activation. (A–C) Comparison of the gene expression profile of the monocytes
isolated from the bone marrow and the spinal cords at the peak of EAE by RNA-Seq analysis. (A) MA-plot of differentially expressed genes in bone marrow monocytes
(Continued)
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FIGURE 5 | vs. spinal cord monocytes, with fold change ≥2 and FDR < 0.05. (B,C) DAVID gene ontology enrichment analysis on biological processes for genes that
were up-regulated (B) or down-regulated (C) in the spinal cord monocytes compared to the bone marrow monocytes, using DAVID bioinformatics resource. (D–F)
Comparison of the gene expression profile of the monocytes and monocyte-derived APCs isolated from the spinal cords at the peak of EAE by RNA-Seq analysis. (D)
MA-plot of differentially expressed genes in spinal cord monocytes vs. spinal cord monocyte-derived APCs, with fold change ≥2 and FDR < 0.05. (E,F) DAVID gene
ontology enrichment analysis on biological processes for genes that were up-regulated (E) or down-regulated (F) in the spinal cord monocyte-derived APCs
compared to the spinal cord monocytes, using DAVID bioinformatics resource.
FIGURE 6 | Monocytes do not differentiate in the bone marrow and the blood during the peak of EAE. (A,B) At the peak of EAE (days 14–15), cells from the bone
marrow (A) and the blood (B) were isolated. The expression of CD11c, MHC II, and MerTK was determined in the CD45hi CD11bhi CD64+ cells. Shown are
representative plots from three independent experiments, with a total of 10–11 animals in each time point.
(Figure 2). Together, our data suggest that the expression of
Ccl17, Ccl22, and Ccr7 distinguishes between monocytes and
monocyte-derived APCs in the CNS during the peak of EAE.
We compared the expression of key immunomodulatory
molecules that may be critical to distinguish differences in
function between monocytes and monocyte-derived APCs. In
both cell types, the expression of Cd40, Cd74, Cd80, and
Cd86 was high compared to monocytes isolated from the bone
marrow (Figure 8A). This result is consistent with a recent
study showing that these four genes are considered as APC
signature genes (30). In addition, we found that the expression
of Cd14, Cd24a, Cd38, Cd69, Cd83, Cd164, Cd274, and Cd300lf
was high in the monocytes isolated from the spinal cord,
and the expression was maintained in the monocyte-derived
APCs (Figure 8A). Moreover, similar to the expression of Cd74
(Figure 4F), expression of Cd9, Cd63, and Cd81 was higher in
the spinal cord monocytes compared to the monocytes from
the bone marrow, and these genes were further up-regulated
when differentiation occurred (Figures 8B–D). All three genes
encode tetraspanins that were previously described to control
monocyte fusion to form multinucleate giant cells (43). Taken
together, our data suggest that monocytes and monocyte-derived
cells commonly express several proinflammatory cytokine and
chemokine genes during the peak of EAE, and the expression
of genes related to antigen-presentation are further up-regulated
when differentiation occurs.
Atf3 Is Induced in Monocytes That
Migrated Into the CNS During EAE
We identified transcription factors that had altered expression
during monocyte differentiation in the CNS. The expression
of 13 transcription factors was reduced during monocyte
differentiation, but only two (Bhlhe41, Mef2c) were increased.
Atf3 was among the transcription factors that was most
significantly expressed in the monocytes from the spinal cord.
Its expression was reduced by half in monocyte-derived APCs
(Figure 9). A recent study has shown that ATF3 promotes
M2 polarization of macrophages in vitro (44). Whether ATF3
controls monocyte differentiation during EAE is not known. The
expression of several transcription factors, including Daxx, Id1,
Id3, Nrg1, and Tet1, followed the same pattern as Atf3, whereas
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FIGURE 7 | The expression of Ccl17, Ccl22, and Ccr7 distinguishes monocytes from monocyte-derived APCs. (A–D) Heatmaps showing the differential expression
of genes that encode cytokines (A), cytokine receptors (B), chemokines (C), and chemokine receptors (D) from bone marrow monocytes relative to the spinal cord
monocytes, and/or spinal cord monocytes relative to the spinal cord monocyte-derived APCs. Colors on the heatmap represent log2 values of TPM. (E–G) Gene
expression level of Ccl17 (E), Ccl22 (F), Ccr7 (G) in monocytes isolated from the bone marrow (BM-Mono) or spinal cords (SC-Mono), and the monocyte-derived
APCs isolated from the spinal cords (SC-APC) at days 14–15 following EAE induction. Shown are TPM values from RNA-Seq analysis.
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FIGURE 8 | Genes encoding tetraspanins are regulated during monocyte differentiation in the CNS. (A) Heatmap showing the differential expression of genes that
encode a selected group of immunomodulatory molecules from bone marrow monocytes relative to the spinal cord monocytes, and/or spinal cord monocytes relative
to the spinal cord monocyte-derived APCs. Colors on the heatmap represent log2 values of TPM. (B–D) Gene expression level of Cd9 (B), Cd63 (C), Cd81 (D) in
monocytes isolated from the bone marrow (BM-Mono) or spinal cords (SC-Mono), and the monocyte-derived APCs isolated from the spinal cords (SC-APC) at days
14–15 following EAE induction. Shown are TPM values from RNA-Seq analysis.
the expression level of Bach1, Camta1, Esrra, Hopx, Jarid2, Rara,
and Zfp961 was similar in the bone marrow and spinal cord
monocytes, but was reduced during monocyte differentiation.
Comparing the expression of transcription factors between these
cell subsets may shed light on molecular signals that control
monocyte differentiation in the CNS during EAE.
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FIGURE 9 | Atf3 is induced in CNS-infiltrated monocytes during EAE. Graph shows the differential expression of genes that encode transcription factors, which are
differentially expressed in monocytes relative to the monocyte-derived APCs isolated from the spinal cords at days 14–15 following EAE induction. Shown are TPM
values from RNA-Seq analysis.
DISCUSSION
To our knowledge, this is the first report to identify distinct gene
signatures that can be used to distinguish between monocytes
and monocyte-derived APCs in the CNS during inflammation.
Although previous studies identified gene signatures that
represent the subsets of myeloid cells in the CNS during EAE,
those studies most often used the expression of Ly6c and Ccr2
to identity monocytes and monocyte-derived cells as a single
population of cells, and utilized the CCR2-repoter mouse strain
to determine the locations and functions of these cells in vivo.
Here we show that the expression of Ccl17, Ccl22, and Ccr7
can be used to further distinguish between these cell types.
Monocyte infiltration into the CNS is thought to solely promote
inflammation and tissue damage during EAE. As such, a CCR2
antagonist, MK-0812, had entered a phase 2 clinical trial for
treating patients with relapsing-remitting MS (NCT00239655).
However, the trial was terminated and no positive results
have been reported. Two recent studies have demonstrated
that during the course of EAE, CNS-infiltrated monocytes
differentiate first into an inducible nitric oxide synthase (iNOS)-
expressing, proinflammatory state, followed by a further shift
into an arginase-1 (Arg1)-expressing immune modulatory state,
which may facilitate tissue repair (45, 46). This suggests that
completely blocking monocyte migration into the CNS may
eliminate their beneficial role in resolving inflammation. Thus,
understanding the molecular signals that trigger monocyte
differentiation is critical for developing immunomodulatory
strategies to specifically target the deleterious effect
of monocytes.
Molecular signals that control monocyte differentiation are
not well-understood but are believed to be multifactorial
and likely include general inflammatory mediators and those
mediators which are tissue-specific. In this regard, comparison
of our data with other published gene expression studies of the
Ly6C+ cells isolated from various inflammatory conditions may
provide insight on the tissue-specific monocyte differentiation.
We showed that the expression of Csf1r and Csf2r was
high in the monocytes and further increased following their
differentiation. CSF1 receptor signaling is critical for the
tissue non-specific differentiation of monocytes under various
inflammatory conditions and is defined by the expression of
CD11c andMHC II. GM-CSF, which acts through CSF2 receptor,
is dispensable for the production of iNOS and TNF-α in
monocytes (47). However, several lines of evidence support the
notion that GM-CSF signaling in monocytes is critical for CNS
pathogenicity during EAE (48, 49). The combined impact of
CSF1 and CSF2 receptor signaling on monocyte differentiation
and function requires further investigation. Moreover, the
expression of several γc family receptors were detected in the
monocytes and monocyte-derived APCs in the CNS, including
receptor for IL-4, IL-7, IL-15, and IL-21. The combination of
GM-CSF and IL-4 is known to induce the differentiation of
monocytes into dendritic cells in vitro (50, 51). In addition,
GM-CSF-induced monocyte differentiation into dendritic cells
is enhanced by IL-15 but inhibited by IL-21 (52). The role of
these γc cytokines and their cellular source during EAE remains
to be elucidated.
Our findings suggest that Ccl17 and Ccl22 may serve
as signature genes for the monocyte-derived APCs. These
chemokines were also demonstrated to promote EAE pathology
(41). Mice lacking CCL17, CCL22, or their receptor, CCR4,
are partially resistant to the development of EAE (40, 42, 53).
These chemokines seem to promote EAE by enhancing myeloid
cell migration and their production of TNF (40, 53). GM-
CSF was found to be the main stimulant for the production
of CCL17 in monocytes (39). Indeed, we found that GM-CSF
induces the expression of CCL17 and CCL22 in monocytes,
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which is dependent on the activation of STAT5 tetramerization
(Monaghan et al., manuscript in preparation). Future research
can explore the possibility of targeting CCL17 and CCL22 for
treating EAE and MS.
An important question that remains to be addressed is
whether all monocyte-derived APCs defined by our gating
strategy expressCcl17,Ccl22, andCcr7, given that this population
of cells may be heterogenous in nature. One possibility is
that some cells within the monocyte-derived APC population
express high levels of these genes, whereas other cells do
not. In this regard, single-cell gene expression analysis or the
use of reporter mice (e.g., Ccl17-reporter mice) may provide
further insight.
Our RNA-Seq analysis has shown that monocytes, once
migrated to the CNS and prior cell differentiation, highly
expressed proinflammatory cytokines, such as Il1b,Osm, andTnf,
and chemokines, such as Cxcl2 and Cxcl10 that have been shown
to promote the pathogenesis of EAE (54, 55). The expression
of genes that are critical for antigen presentation, such as H2-
Ab1,H2-Aa, Cd74were significantly induced in the differentiated
APCs. This suggests that differentiation of monocytes increases
their antigen-presentation capability, which is known to be a
critical and distinctive function of the monocyte-derived APCs
compared to the CNS-resident macrophages and macroglia (30).
Based on surface marker expression, these cells co-expressed
markers for dendritic cells and macrophages, although cells
that only expressed markers of either cell type could not
be excluded.
CONCLUSION
In summary, we have shown that monocytes and monocyte-
derived APCs in the CNS have distinct gene expression profiles
during EAE, and found that expression of Ccl17, Ccl22, and
Ccr7 can be used to distinguish between monocyte-derived
APCs and the undifferentiated monocytes. In the past, the
monocyte-derived APCs are often described in the literature
as monocyte-derived macrophages, monocytes/macrophages, or
simply monocyte-derived myeloid cells. We propose that this
population of cells can be better named as monocyte-derived
inflammatory APCs.
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